Abstract
Substantial research has focused on the discovery of urinary biomarkers to detect acute kidney injury (AKI) before a rise in serum creatinine. As in chronic kidney diseases, the concentrations of urinary AKI biomarkers have been normalized to urine creatinine concentration to account for creatinine clearance and urine flow. Waikar et al. challenge the assumption that normalization to creatinine clearance in a chronic disease state can be extrapolated to an acute state, in which creatinine clearance is, by definition, changing acutely.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
